| Mr Marc L Simpkins, CRNA | |
|
4500 13th St, Gulfport, MS 39501-2515 | |
| (228) 818-0563 | |
| (228) 818-0519 |
| Full Name | Mr Marc L Simpkins |
|---|---|
| Gender | Male |
| Speciality | Anesthesiology |
| Location | 4500 13th St, Gulfport, Mississippi |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1134298284 | NPI | - | NPPES |
| 00123092 | Medicaid | MS |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207L00000X | Anesthesiology | R851226 (Mississippi) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Mr Marc L Simpkins, CRNA 22 Doctors Dr, Suite C, Ocean Springs, MS 39564 Ph: (228) 818-0563 | Mr Marc L Simpkins, CRNA 4500 13th St, Gulfport, MS 39501-2515 Ph: (228) 818-0563 |
News Archive
Acceleron Pharma, Inc., a biopharmaceutical company developing novel therapeutics that modulate the growth of cells and tissues including muscle, bone, fat, red blood cells and the vasculature, today announced the initiation of a Phase 2 clinical trial with ACE-031 in patients with Duchenne Muscular Dystrophy (DMD), a fatal neuromuscular disease. ACE-031 is an investigational protein therapeutic that builds muscle and increases strength by inhibiting signaling of a cell surface receptor called the activin receptor type IIB (ActRIIB).
EnVivo Pharmaceuticals today reported the successful reduction in the levels of aggregated Abeta or Beta-Amyloid in an aged transgenic model (Tg2576) of Alzheimer's disease with its lead gamma-secretase modulator (GSM) EVP-0962. The aggregated Abeta, containing predominately oligomeric and larger Abeta fibrillar species, is considered to be the toxic entity in Alzheimer's disease.
The American Gastroenterological Association (AGA) has announced the third class of its Future Leaders Program, which was created in 2015 to provide a pathway for leadership development within AGA for early career physicians and scientists who have the potential to make a significant impact on the specialty.
Ten-year follow-up results of the U.S. Investigational Device Exemption Trial of the Melody transcatheter pulmonary valve were presented today during the SCAI 2020 Scientific Sessions Virtual Conference.
› Verified 1 days ago
Stanley Turner, CRNA Anesthesiology Medicare: Not Enrolled in Medicare Practice Location: 4500 13th St, Gulfport, MS 39501 Phone: 228-818-0563 Fax: 228-818-0519 | |
Davis Hutto, CRNA Anesthesiology Medicare: Not Enrolled in Medicare Practice Location: 4500 13th St, Gulfport, MS 39501 Phone: 228-818-0563 Fax: 228-818-0519 | |
Matthew Blanchard, MD Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 15476 Dedeaux Rd Ste B, Gulfport, MS 39503 Phone: 228-230-2663 Fax: 228-546-3257 | |
Juanita Derouen, CRNA Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 4500 13th St, Gulfport, MS 39501 Phone: 228-818-0563 Fax: 228-818-0519 | |
Dr. John C Briggs, M.D. Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 4500 13th St, Gulfport, MS 39501 Phone: 228-867-4000 | |
Ronald P. Bernadas, M.D. Anesthesiology Medicare: Medicare Enrolled Practice Location: 15190 Community Rd Ste 230a, Gulfport, MS 39503 Phone: 228-831-0204 Fax: 228-831-1868 |